Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Articolo
Data di Pubblicazione:
2017
Citazione:
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer / Hanker, Ab; Estrada, Mv; Bianchini, G; Moore, Pd; Zhao, J; Cheng, F; Koch, Jp; Gianni, L; Tyson, Dr; Sánchez, V; Rexer, Bn; Sanders, Me; Zhao, Z; Stricker, Tp; Arteaga, Cl.. - In: CANCER RESEARCH. - ISSN 0008-5472. - (2017).
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Hanker, Ab; Estrada, Mv; Bianchini, G; Moore, Pd; Zhao, J; Cheng, F; Koch, Jp; Gianni, L; Tyson, Dr; Sánchez, V; Rexer, Bn; Sanders, Me; Zhao, Z; Stricker, Tp; Arteaga, Cl.
Link alla scheda completa:
Pubblicato in: